HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of twice daily administration of cefpirome in the empiric treatment of sepsis.

Abstract
Cefpirome is a fourth-generation cephalosporin with good activity against both gram-positive and gram-negative bacteria. A multicentre trial was performed to study the efficacy and safety of cefpirome 2 g twice daily in the treatment of sepsis. Sixty-three cases were recruited from 10 hospitals from April 1996 to January 1998. Fifty seven cases could be evaluated according to the protocol. The APACHE II score was used to measure severity of illness, with 46.9 per cent of patients having APACHE II score more than 10 and two patients more than 20; both were cured. The most common pathogens were gram-negative bacteria with E. coli predominating 16/40 (40.0%), followed by Klebsiella 8/40 (20.0%). The overall clinical success rates were 54 out of 57 patients (94.7%). In patients with positive blood culture, the clinical cures were achieved for 20/22 (90.9%). Cefpirome showed good efficacy and safety in the empirical treatment of suspected bacteremia or sepsis.
AuthorsP Suwangool, C Suttinont, C Bowonwatanuwong, A Rajanuwong, S A Kulpradist, V Dusitnanond, P Chayakul, P Chetchotisakd, S Leelasupasri, N Aswapokee
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 82 Issue 7 Pg. 648-53 (Jul 1999) ISSN: 0125-2208 [Print] Thailand
PMID10511765 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Cephalosporins
  • cefpirome
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacteremia (drug therapy, microbiology)
  • Cephalosporins (administration & dosage, adverse effects)
  • Drug Administration Schedule
  • Female
  • Follow-Up Studies
  • Gram-Negative Bacterial Infections (drug therapy, microbiology)
  • Gram-Positive Bacterial Infections (drug therapy, microbiology)
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: